{"gene":"SLC6A4","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1993,"finding":"The human serotonin transporter (SERT/SLC6A4) was molecularly cloned from placenta, revealing a 630-amino acid protein with 12 predicted transmembrane segments, Na⁺- and Cl⁻-dependent high-affinity serotonin transport (Km ~463 nM), and sensitivity to antidepressants (paroxetine, fluoxetine, imipramine) and cocaine/amphetamine. The gene was mapped to chromosome 17q11.1–17q12 and shown to encode both brain and platelet 5-HT transporters.","method":"cDNA cloning, transfection into HeLa cells, radiotracer uptake assay, pharmacological inhibition, somatic cell hybrid mapping, in situ hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — original functional reconstitution in heterologous cells with transport kinetics, pharmacology, and chromosomal mapping; independently confirmed by concurrent platelet SERT cloning","pmids":["7681602"],"is_preprint":false},{"year":1993,"finding":"The primary structure of human platelet SERT (SLC6A4) is identical to the brain serotonin transporter, encoded by a single gene on chromosome 17. The 630-aa protein contains two putative N-glycosylation sites in the second extracellular loop, consensus phosphorylation sites for cAMP-dependent protein kinase in the N-terminal cytoplasmic region, and three potential PKC phosphorylation sites.","method":"PCR-based cDNA cloning and sequencing, hydropathicity analysis, chromosomal assignment","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct sequence determination with structural prediction; replicated by simultaneous independent cloning (PMID 7681602)","pmids":["7684072"],"is_preprint":false},{"year":1994,"finding":"The human SLC6A4 gene spans approximately 31 kb and is composed of 14 exons. A variable number tandem repeat (VNTR) polymorphism was identified within the gene, providing the first structural framework for genetic studies of serotonin transporter regulation.","method":"Genomic library screening, exon mapping, DNA sequencing","journal":"Journal of neural transmission. General section","confidence":"High","confidence_rationale":"Tier 1 — direct genomic characterization; foundational structural finding repeatedly referenced","pmids":["7865169"],"is_preprint":false},{"year":1996,"finding":"A polymorphic repetitive element in the 5'-flanking transcriptional regulatory region of SLC6A4 (5-HTTLPR) drives allele-dependent differential promoter activity: the long (L) allele confers approximately 2–3-fold higher basal transcription and 5-HT transporter expression than the short (S) allele in transfected cells and lymphoblasts, establishing this as a functional regulatory variant.","method":"Reporter gene (luciferase) transfection assays in serotonergic and non-serotonergic cells, lymphoblast 5-HTT expression analysis","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — functional promoter assays with allele-specific constructs; one of the most-cited mechanistic findings for this gene","pmids":["8632190"],"is_preprint":false},{"year":1996,"finding":"The recombinant rat serotonin transporter SERT1 expressed in HEK293 cells forms oligomeric complexes: treatment with sulfhydryl-oxidizing agents and the homobifunctional cross-linker DMS generated adducts of 130–180 kDa and 220–270 kDa, indicating that the membrane-bound transporter has a quaternary oligomeric structure.","method":"Transient transfection in HEK293 cells, chemical cross-linking (dimethyl suberimidate), SDS-PAGE/immunoblot","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — chemical cross-linking in heterologous cells; single study, rat ortholog","pmids":["8925924"],"is_preprint":false},{"year":1996,"finding":"The STin2 VNTR in intron 2 of SLC6A4 is a polymorphic transcriptional regulatory element; the nine-copy repeat allele (STin2.9) is significantly associated with unipolar depressive disorder, providing the first evidence that intronic variation in SLC6A4 may affect gene expression and disease risk.","method":"PCR genotyping, case-control association study, allele frequency comparison","journal":"Lancet","confidence":"Low","confidence_rationale":"Tier 3 — association study; mechanistic link to expression is inferred, not directly demonstrated in this paper","pmids":["8602004"],"is_preprint":false},{"year":2004,"finding":"The SLC6A4 intron 2 VNTR is a transcriptional regulatory domain whose allelic variants drive differential reporter gene expression in vivo and in vitro. Yeast one-hybrid screening identified the transcription factor YB-1 as a sequence-specific VNTR-binding activator; CTCF (CCTC-binding factor) blocks YB-1 binding to VNTR sequences and antagonizes YB-1-directed reporter expression, providing a molecular mechanism for allele-dependent differential transcription.","method":"Yeast one-hybrid screening, reporter gene assays, electrophoretic mobility shift assay (EMSA), in vitro binding assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — yeast one-hybrid plus in vitro EMSA plus reporter assays converging on same conclusion; multiple orthogonal methods in one study","pmids":["15229244"],"is_preprint":false},{"year":2004,"finding":"Mucosal serotonin transporter (SERT) mRNA and protein are significantly reduced in patients with ulcerative colitis, IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C), without a corresponding decrease in enterochromaffin cell numbers or basal/stimulated 5-HT release, implicating defective 5-HT reuptake via SLC6A4 as an intrinsic gastrointestinal molecular defect in these disorders.","method":"Rectal biopsy analysis, quantitative RT-PCR for SERT mRNA, immunohistochemistry for SERT protein, 5-HT release assays","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — multiple molecular methods (mRNA, protein, functional release assay) in human tissue; replicated across multiple disease groups","pmids":["15188158"],"is_preprint":false},{"year":2004,"finding":"The 5-HTTLPR short allele of SLC6A4 is associated with reduced gray matter volume in perigenual anterior cingulate cortex and amygdala, and with relative uncoupling of the amygdala–cingulate feedback circuit during processing of fearful stimuli. The magnitude of amygdala-cingulate coupling inversely predicted ~30% of variation in temperamental anxiety, establishing a developmental, systems-level neural mechanism for the genetic susceptibility conferred by the short allele.","method":"Multimodal neuroimaging (structural MRI volumetry + fMRI functional connectivity), large healthy-subject cohort (N≈114)","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — two orthogonal neuroimaging modalities in a large sample; replicated amygdala finding from prior work and extended to structural and circuit level","pmids":["15880108"],"is_preprint":false},{"year":2004,"finding":"Carriers of the SLC6A4 short allele show stronger amygdala activation and greater functional coupling between amygdala and ventromedial prefrontal cortex during presentation of aversive stimuli compared with long-allele homozygotes, directly linking SERT genotype to amygdala-prefrontal serotonergic circuitry.","method":"fMRI (BOLD), genotyping of 5-HTTLPR, passive viewing of aversive vs. neutral pictures","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — independent replication of amygdala hyperreactivity finding with added prefrontal connectivity; multiple independent labs","pmids":["15592465"],"is_preprint":false},{"year":2006,"finding":"The 5-HTTLPR is functionally triallelic: a common G→A substitution (rs25531) within the L allele creates an AP2 transcription-factor binding site, converting the L allele into a low-expressing L(G) allele functionally equivalent to the S allele. Expression assays in 62 lymphoblastoid cell lines demonstrated codominant allele action, with the L(A)/L(A) genotype conferring highest expression (~2-fold over S or L(G)). The gain-of-function L(A)/L(A) genotype was ~2-fold more common in OCD patients, establishing SERT overexpression as a risk mechanism for OCD.","method":"Luciferase reporter assays in raphe-derived cells, allele-specific expression in 62 lymphoblastoid lines, case-control genotyping (OCD probands + trios), transmission disequilibrium test","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1-2 — reporter assays plus lymphoblastoid expression across 62 cell lines plus TDT replication; multiple orthogonal methods identifying a functional triallelic mechanism","pmids":["16642437"],"is_preprint":false},{"year":2006,"finding":"ITGB3 (integrin beta-3) and SLC6A4 expression levels are correlated (r = 0.38–0.78) in murine and human datasets, and genetic variation in ITGB3 is associated with expression of both ITGB3 (P=0.012) and SLC6A4 (P=0.008), suggesting that ITGB3 acts as a trans-regulator of SLC6A4 expression and that epistatic interaction between the two genes influences serotonin levels.","method":"Public expression database analysis (murine and human), eQTL analysis in CEPH individuals, genetic association","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 3-4 — expression correlation and eQTL from existing databases; no direct functional experiment demonstrating mechanism","pmids":["16721604"],"is_preprint":false},{"year":2008,"finding":"SLC6A4 (5-HTTLPR S allele) and BDNF (Val66Met) exhibit biological epistasis at the neural systems level: the BDNF Met allele (which reduces BDNF secretion and 5-HT responsivity) protects against S-allele-driven volume reduction of the subgenual anterior cingulate cortex and against reduced structural connectivity between amygdala and anterior cingulate, demonstrating a gene–gene interaction between serotonergic and neurotrophic signaling pathways in emotion circuitry.","method":"Structural MRI volumetry and diffusion tensor imaging (structural connectivity) in healthy subjects (N=111), two-way ANOVA for genotype interaction","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — two neuroimaging modalities in a reasonably sized sample; single lab but orthogonal structural measures converge","pmids":["18347599"],"is_preprint":false},{"year":2011,"finding":"5-HTT-deficient (SLC6A4 knockout) mice show impaired recall of conditioned fear extinction and delayed extinction learning, accompanied by increased theta synchronization between the lateral amygdala and infralimbic medial prefrontal cortex during extinction, establishing a causal role for SERT in amygdala-prefrontal circuit oscillatory dynamics underlying fear regulation.","method":"5-HTT knockout mouse model, Pavlovian fear conditioning, simultaneous local field potential recordings in lateral amygdala and mPFC, resident-intruder social defeat paradigm","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with simultaneous electrophysiological recordings and behavioral readout; direct mechanistic link between SERT loss and circuit-level oscillatory phenotype","pmids":["21818344"],"is_preprint":false},{"year":2013,"finding":"Gain-of-function SERT alleles (high-expressing 5-HTTLPR L(A) allele and the rare coding variant I425V) are enriched in Tourette's disorder probands, with I425V found at 1.57% in OCD/TD spectrum vs. 0.15% in controls, indicating that SERT overactivity (not just underactivity) contributes to serotonergic abnormalities in TD.","method":"Case-control genotyping (N=151 TD probands, N=858 controls), triallelic 5-HTTLPR/rs25531/rs25532 haplotyping, rare variant (I425V) sequencing","journal":"Movement disorders","confidence":"Medium","confidence_rationale":"Tier 3 — genetic association with functional alleles; mechanism inferred from known functional consequences of these variants","pmids":["23630162"],"is_preprint":false},{"year":2014,"finding":"Mice with compromised 5-HTT function (genetic deletion or neonatal SSRI treatment) exhibit amplified 5-HT1A receptor-mediated inhibitory currents in prefrontal pyramidal neurons, with enhanced downstream coupling to Kir3 channels. This hyperresponsiveness is due to loss of tyrosine kinase-dependent inhibitory control: in wild-type mice, Src family tyrosine kinase inhibition mimics the amplified 5-HT1A response, while tyrosine phosphatase inhibition reduces it in 5-HTT-deficient mice.","method":"Whole-cell patch-clamp electrophysiology in prefrontal cortex slices, 5-HTT knockout mice, neonatal fluoxetine treatment, pharmacological manipulation of tyrosine kinases and phosphatases","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro electrophysiology with genetic KO plus pharmacological rescue; identifies a specific tyrosine kinase signaling mechanism linking SERT to 5-HT1A receptor regulation","pmids":["24760870"],"is_preprint":false},{"year":2016,"finding":"X-ray crystallographic structures of human SERT (SLC6A4) at 3.15 Å resolution bound to antidepressants (S)-citalopram or paroxetine reveal that these drugs lock SERT in an outward-open conformation by occupying the central binding site between TM helices 1, 3, 6, 8, and 10, directly blocking serotonin access. An allosteric site was identified at the periphery of the extracellular vestibule between EL4/EL6 and TM1/6/10/11; occupancy of this site sterically hinders ligand unbinding from the central site, explaining (S)-citalopram's allosteric action.","method":"X-ray crystallography of thermostabilized human SERT at 3.15 Å, co-crystallization with (S)-citalopram and paroxetine, structure–function analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution crystal structures of the human transporter with bound drugs; defines transport mechanism and two drug-binding sites","pmids":["27049939"],"is_preprint":false},{"year":2018,"finding":"The Gulf toadfish SERT (SLC6A4 ortholog) encodes a 673-aa protein with 83% similarity to zebrafish SERT. When expressed in Xenopus oocytes, it demonstrates Na⁺/Cl⁻-dependent serotonin transport with a Km of 2.08 μmol/l, similar to zebrafish and human SERT. Systemic SSRI (fluoxetine) administration dose-dependently increases plasma 5-HT, indicating that peripheral SERT normally maintains low circulating 5-HT in teleosts lacking platelets.","method":"cRNA expression in Xenopus oocytes, radiotracer uptake kinetics, in vivo fluoxetine administration with plasma 5-HT measurement","journal":"The Journal of experimental biology","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution in Xenopus oocytes with transport kinetics, combined with in vivo pharmacological validation; teleost ortholog","pmids":["29487159"],"is_preprint":false}],"current_model":"SLC6A4 encodes the serotonin transporter (SERT), a Na⁺/Cl⁻-dependent 12-transmembrane-segment protein that mediates high-affinity reuptake of serotonin from the synapse; X-ray structures at 3.15 Å show antidepressants (SSRIs) lock SERT in an outward-open conformation by occupying the central substrate-binding site, while an allosteric site in the extracellular vestibule modulates drug unbinding; the 5-HTTLPR promoter polymorphism and triallelic rs25531 variant drive allele-dependent differential transcription (regulated by YB-1/CTCF at the intron 2 VNTR), with the low-expressing short allele linked to amygdala hyperreactivity, uncoupling of the amygdala–cingulate fear-extinction circuit, and altered prefrontal 5-HT1A receptor signaling via tyrosine kinase-dependent mechanisms; SERT also forms oligomers at the membrane and is functionally deficient in gastrointestinal disorders including IBS and ulcerative colitis."},"narrative":{"teleology":[{"year":1993,"claim":"Molecular cloning of human SERT from placenta and platelets established that a single gene on chromosome 17q encodes a 630-aa, 12-TM protein responsible for Na⁺/Cl⁻-dependent, antidepressant-sensitive 5-HT reuptake in both brain and periphery, resolving the molecular identity of the serotonin transporter.","evidence":"cDNA cloning, HeLa cell reconstitution with radiotracer uptake and pharmacological inhibition, somatic cell hybrid mapping","pmids":["7681602","7684072"],"confidence":"High","gaps":["Post-translational modifications predicted from sequence but not functionally validated","Oligomeric state in native membranes unknown","Three-dimensional structure unresolved"]},{"year":1996,"claim":"Identification of the 5-HTTLPR promoter polymorphism demonstrated that common genetic variation directly modulates SLC6A4 transcription, with the long allele conferring ~2–3-fold higher expression than the short allele, providing the first functional regulatory variant for the serotonin system.","evidence":"Luciferase reporter assays in serotonergic and non-serotonergic cells, lymphoblast expression analysis","pmids":["8632190"],"confidence":"High","gaps":["Chromatin context and in vivo transcription rates not assessed","Effect of the intron 2 VNTR on expression not yet mechanistically dissected","Whether S-allele effect is cell-type-specific was untested"]},{"year":2004,"claim":"Converging neuroimaging and molecular studies showed that the low-expressing S allele reduces cingulate/amygdala gray matter volume and uncouples the amygdala–anterior cingulate feedback circuit during fear processing, while molecular work identified YB-1 and CTCF as antagonistic transcription factors mediating allele-dependent expression at the intron 2 VNTR, establishing both neural systems-level and molecular mechanisms for genetic risk.","evidence":"Structural MRI and fMRI functional connectivity in large cohorts; yeast one-hybrid, EMSA, and reporter assays for VNTR regulators; mucosal biopsy qRT-PCR and immunohistochemistry in GI disease","pmids":["15880108","15592465","15229244","15188158"],"confidence":"High","gaps":["Causal direction from genotype to circuit phenotype not established (observational imaging)","YB-1/CTCF mechanism demonstrated with reporters but not at endogenous locus","Mechanism of mucosal SERT downregulation in IBS/UC not identified"]},{"year":2006,"claim":"Discovery that rs25531 renders 5-HTTLPR functionally triallelic—with L(G) equivalent to S—refined the genetic architecture of SLC6A4 expression and linked the high-expressing L(A)/L(A) genotype to OCD risk, demonstrating that SERT overexpression, not only underexpression, can be pathogenic.","evidence":"Luciferase reporter assays in raphe-derived cells, allele-specific expression across 62 lymphoblastoid lines, transmission disequilibrium test in OCD trios","pmids":["16642437"],"confidence":"High","gaps":["No direct measurement of synaptic 5-HT clearance by genotype in human brain","OCD association not yet replicated in large independent cohorts at time of publication","How overexpression leads to OCD-spectrum phenotypes mechanistically was unresolved"]},{"year":2011,"claim":"Serotonin transporter knockout mice exhibited impaired fear extinction recall with increased amygdala–prefrontal theta synchrony, causally linking SERT loss to oscillatory dysfunction in the fear-extinction circuit and going beyond the correlational human imaging data.","evidence":"5-HTT knockout mice with simultaneous local field potential recordings in lateral amygdala and mPFC during fear conditioning","pmids":["21818344"],"confidence":"High","gaps":["Whether circuit phenotype is developmental or acute consequence of SERT loss is unresolved","Rescue by SERT re-expression not performed","Translational relevance to human S-allele carriers is indirect"]},{"year":2014,"claim":"Electrophysiology in prefrontal cortex slices from 5-HTT-deficient mice identified a specific intracellular mechanism: loss of SERT amplifies 5-HT1A receptor–Kir3 channel coupling through reduced Src-family tyrosine kinase–dependent inhibitory control, explaining how transporter loss reshapes postsynaptic serotonergic signaling.","evidence":"Whole-cell patch-clamp in PFC slices from KO and neonatal fluoxetine-treated mice, pharmacological manipulation of tyrosine kinases and phosphatases","pmids":["24760870"],"confidence":"High","gaps":["Specific Src-family kinase isoform responsible not identified","Whether this mechanism operates in human cortex is untested","Relationship between amplified 5-HT1A signaling and behavioral phenotypes not directly demonstrated"]},{"year":2016,"claim":"The first X-ray crystal structures of human SERT resolved the atomic basis of antidepressant action: SSRIs occupy a central substrate-binding site between TM helices to lock an outward-open state, while an allosteric vestibular site explains the slow off-rate of (S)-citalopram, providing a structural framework for drug design.","evidence":"3.15 Å X-ray crystallography of thermostabilized human SERT co-crystallized with (S)-citalopram and paroxetine","pmids":["27049939"],"confidence":"High","gaps":["Structures captured only outward-open state; inward-open and occluded conformations unresolved","Substrate (5-HT)-bound structure not obtained","Thermostabilizing mutations may alter conformational dynamics"]},{"year":null,"claim":"Key unresolved questions include the complete transport cycle structural dynamics (inward-open, occluded states with substrate), the cell-type-specific mechanisms governing mucosal SERT downregulation in gastrointestinal disease, whether SERT oligomerization is functionally required for transport in vivo, and the causal chain from 5-HTTLPR genotype through circuit-level phenotypes to psychiatric disease risk in humans.","evidence":"","pmids":[],"confidence":"High","gaps":["No substrate-bound or inward-facing structural state resolved","SERT oligomeric stoichiometry and functional relevance in native membranes uncharacterized","Causal genotype-to-disease pathway remains incompletely bridged in humans"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,16,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,4,16]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,9,13,15]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,16,17]}],"complexes":[],"partners":["YBX1","CTCF"],"other_free_text":[]},"mechanistic_narrative":"SLC6A4 encodes the sodium- and chloride-dependent serotonin transporter (SERT), a 630-amino-acid, 12-transmembrane-segment protein that mediates high-affinity reuptake of 5-HT from the extracellular space in both the central nervous system and peripheral tissues, thereby terminating serotonergic signaling [PMID:7681602, PMID:7684072]. X-ray crystallography of human SERT at 3.15 Å resolution shows that SSRI antidepressants lock the transporter in an outward-open conformation by occupying a central substrate-binding site between TM1/3/6/8/10, while an allosteric vestibular site sterically impedes drug unbinding [PMID:27049939]. Transcription from SLC6A4 is regulated by the functionally triallelic 5-HTTLPR/rs25531 promoter polymorphism, where the L(A) allele drives ~2-fold higher expression than the S or L(G) alleles, and by an intron 2 VNTR whose activity is modulated by YB-1 binding opposed by CTCF [PMID:16642437, PMID:15229244]. Loss of SERT function—whether by the low-expressing S allele, genetic knockout, or pharmacological inhibition—results in amygdala hyperreactivity, uncoupling of amygdala–anterior cingulate fear-extinction circuitry, and amplified prefrontal 5-HT1A receptor signaling via loss of Src-family tyrosine kinase–dependent inhibitory control [PMID:15880108, PMID:21818344, PMID:24760870]."},"prefetch_data":{"uniprot":{"accession":"P31645","full_name":"Sodium-dependent serotonin transporter","aliases":["5HT transporter","5HTT","Solute carrier family 6 member 4"],"length_aa":630,"mass_kda":70.3,"function":"Serotonin transporter that cotransports serotonin with one Na(+) ion in exchange for one K(+) ion and possibly one proton in an overall electroneutral transport cycle. Transports serotonin across the plasma membrane from the extracellular compartment to the cytosol thus limiting serotonin intercellular signaling (PubMed:10407194, PubMed:12869649, PubMed:21730057, PubMed:27049939, PubMed:27756841, PubMed:34851672). Essential for serotonin homeostasis in the central nervous system. In the developing somatosensory cortex, acts in glutamatergic neurons to control serotonin uptake and its trophic functions accounting for proper spatial organization of cortical neurons and elaboration of sensory circuits. In the mature cortex, acts primarily in brainstem raphe neurons to mediate serotonin uptake from the synaptic cleft back into the pre-synaptic terminal thus terminating serotonin signaling at the synapse (By similarity). Modulates mucosal serotonin levels in the gastrointestinal tract through uptake and clearance of serotonin in enterocytes. Required for enteric neurogenesis and gastrointestinal reflexes (By similarity). Regulates blood serotonin levels by ensuring rapid high affinity uptake of serotonin from plasma to platelets, where it is further stored in dense granules via vesicular monoamine transporters and then released upon stimulation (PubMed:17506858, PubMed:18317590). Mechanistically, the transport cycle starts with an outward-open conformation having Na1(+) and Cl(-) sites occupied. The binding of a second extracellular Na2(+) ion and serotonin substrate leads to structural changes to outward-occluded to inward-occluded to inward-open, where the Na2(+) ion and serotonin are released into the cytosol. Binding of intracellular K(+) ion induces conformational transitions to inward-occluded to outward-open and completes the cycle by releasing K(+) possibly together with a proton bound to Asp-98 into the extracellular compartment. Na1(+) and Cl(-) ions remain bound throughout the transport cycle (PubMed:10407194, PubMed:12869649, PubMed:21730057, PubMed:27049939, PubMed:27756841, PubMed:34851672). Additionally, displays serotonin-induced channel-like conductance for monovalent cations, mainly Na(+) ions. The channel activity is uncoupled from the transport cycle and may contribute to the membrane resting potential or excitability (By similarity)","subcellular_location":"Cell membrane; Endomembrane system; Endosome membrane; Synapse; Cell junction, focal adhesion; Cell projection, neuron projection","url":"https://www.uniprot.org/uniprotkb/P31645/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC6A4","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC6A4","total_profiled":1310},"omim":[{"mim_id":"617503","title":"DENN DOMAIN-CONTAINING PROTEIN 3; DENND3","url":"https://www.omim.org/entry/617503"},{"mim_id":"616448","title":"RAS-ASSOCIATED PROTEIN RAB12; RAB12","url":"https://www.omim.org/entry/616448"},{"mim_id":"616417","title":"ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3","url":"https://www.omim.org/entry/616417"},{"mim_id":"613675","title":"CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB","url":"https://www.omim.org/entry/613675"},{"mim_id":"612276","title":"YRDC DOMAIN-CONTAINING PROTEIN; YRDC","url":"https://www.omim.org/entry/612276"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":38.0},{"tissue":"lung","ntpm":27.2},{"tissue":"placenta","ntpm":17.3}],"url":"https://www.proteinatlas.org/search/SLC6A4"},"hgnc":{"alias_symbol":["5-HTT","SERT1"],"prev_symbol":["HTT","OCD1"]},"alphafold":{"accession":"P31645","domains":[{"cath_id":"1.20.1740,1.20.1730","chopping":"104-214_222-620","consensus_level":"medium","plddt":94.1674,"start":104,"end":620}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31645","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31645-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31645-F1-predicted_aligned_error_v6.png","plddt_mean":84.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC6A4","jax_strain_url":"https://www.jax.org/strain/search?query=SLC6A4"},"sequence":{"accession":"P31645","fasta_url":"https://rest.uniprot.org/uniprotkb/P31645.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31645/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31645"}},"corpus_meta":[{"pmid":"12869766","id":"PMC_12869766","title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12869766","citation_count":4885,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31666698","id":"PMC_31666698","title":"Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31666698","citation_count":383,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9361027","id":"PMC_9361027","title":"Serotonin transporter (5-HTT) gene variants associated with autism?","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9361027","citation_count":199,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18347599","id":"PMC_18347599","title":"Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18347599","citation_count":183,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28465506","id":"PMC_28465506","title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28465506","citation_count":171,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18824000","id":"PMC_18824000","title":"How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18824000","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31263285","id":"PMC_31263285","title":"Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.","date":"2019","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31263285","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24459107","id":"PMC_24459107","title":"HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.","date":"2014","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24459107","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16969368","id":"PMC_16969368","title":"Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16969368","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19487392","id":"PMC_19487392","title":"Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population.","date":"2009","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19487392","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30358836","id":"PMC_30358836","title":"FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30358836","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9514579","id":"PMC_9514579","title":"Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514579","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16205790","id":"PMC_16205790","title":"AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance.","date":"2005","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16205790","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17203304","id":"PMC_17203304","title":"Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.","date":"2007","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17203304","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29212816","id":"PMC_29212816","title":"Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29212816","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21818344","id":"PMC_21818344","title":"Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21818344","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22921802","id":"PMC_22921802","title":"Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression.","date":"2012","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/22921802","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15450911","id":"PMC_15450911","title":"Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum.","date":"2004","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/15450911","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31015293","id":"PMC_31015293","title":"Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31015293","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18253134","id":"PMC_18253134","title":"Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.","date":"2008","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/18253134","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23319588","id":"PMC_23319588","title":"An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23319588","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24657235","id":"PMC_24657235","title":"The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression.","date":"2014","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/24657235","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34911927","id":"PMC_34911927","title":"Small molecule splicing modifiers with systemic HTT-lowering activity.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34911927","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21857948","id":"PMC_21857948","title":"Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene × environment interactions.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21857948","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25825812","id":"PMC_25825812","title":"DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli.","date":"2015","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/25825812","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30185623","id":"PMC_30185623","title":"N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30185623","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19776381","id":"PMC_19776381","title":"Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.","date":"2009","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19776381","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26822441","id":"PMC_26822441","title":"Serotonin Transporter Gene (SLC6A4) Methylation Associates With Neonatal Intensive Care Unit Stay and 3-Month-Old Temperament in Preterm Infants.","date":"2016","source":"Child development","url":"https://pubmed.ncbi.nlm.nih.gov/26822441","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23702251","id":"PMC_23702251","title":"A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression.","date":"2013","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/23702251","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18663369","id":"PMC_18663369","title":"Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18663369","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15229244","id":"PMC_15229244","title":"YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15229244","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19387615","id":"PMC_19387615","title":"5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls.","date":"2009","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19387615","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18495314","id":"PMC_18495314","title":"The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls.","date":"2008","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18495314","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17564628","id":"PMC_17564628","title":"A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome.","date":"2007","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/17564628","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8925924","id":"PMC_8925924","title":"The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8925924","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34024231","id":"PMC_34024231","title":"Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34024231","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33344725","id":"PMC_33344725","title":"Increased methylation of NR3C1 and SLC6A4 is associated with blunted cortisol reactivity to stress in major depression.","date":"2020","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/33344725","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20515468","id":"PMC_20515468","title":"pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking.","date":"2010","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/20515468","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29956026","id":"PMC_29956026","title":"Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.","date":"2018","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29956026","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21994396","id":"PMC_21994396","title":"Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21994396","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22457857","id":"PMC_22457857","title":"Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.","date":"2012","source":"Journal of gastrointestinal and liver diseases : JGLD","url":"https://pubmed.ncbi.nlm.nih.gov/22457857","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36357392","id":"PMC_36357392","title":"An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36357392","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17124363","id":"PMC_17124363","title":"LEPR, ADBR3, IRS-1 and 5-HTT genes polymorphisms do not associate with obesity.","date":"2006","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/17124363","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24167611","id":"PMC_24167611","title":"5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167611","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26218986","id":"PMC_26218986","title":"Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26218986","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19779024","id":"PMC_19779024","title":"Interaction of child maltreatment and 5-HTT polymorphisms: suicidal ideation among children from low-SES backgrounds.","date":"2009","source":"Journal of pediatric psychology","url":"https://pubmed.ncbi.nlm.nih.gov/19779024","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34341434","id":"PMC_34341434","title":"Hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants' temperament at 3 months.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34341434","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16507957","id":"PMC_16507957","title":"Stressful life events, 5-HTT genotype and risk of depression.","date":"2006","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/16507957","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30529315","id":"PMC_30529315","title":"BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1.","date":"2018","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/30529315","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25335169","id":"PMC_25335169","title":"Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice.","date":"2014","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25335169","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23630162","id":"PMC_23630162","title":"Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.","date":"2013","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/23630162","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25689972","id":"PMC_25689972","title":"Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy.","date":"2015","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25689972","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31810584","id":"PMC_31810584","title":"Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.","date":"2019","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/31810584","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23518607","id":"PMC_23518607","title":"Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder.","date":"2013","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23518607","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16721604","id":"PMC_16721604","title":"ITGB3 shows genetic and expression interaction with SLC6A4.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16721604","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29608652","id":"PMC_29608652","title":"Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29608652","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24815315","id":"PMC_24815315","title":"Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: a reciprocal risk factor for depression and insulin resistance?","date":"2014","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24815315","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25889020","id":"PMC_25889020","title":"Methylation of NR3C1 and SLC6A4 and internalizing problems. The TRAILS study.","date":"2015","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25889020","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35082301","id":"PMC_35082301","title":"Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35082301","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28821725","id":"PMC_28821725","title":"Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28821725","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17548158","id":"PMC_17548158","title":"Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17548158","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10771175","id":"PMC_10771175","title":"Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients.","date":"2000","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10771175","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35793238","id":"PMC_35793238","title":"Alternative processing of human HTT mRNA with implications for Huntington's disease therapeutics.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35793238","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34888656","id":"PMC_34888656","title":"Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34888656","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25261775","id":"PMC_25261775","title":"SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population.","date":"2014","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25261775","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28650965","id":"PMC_28650965","title":"Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitus.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28650965","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27381173","id":"PMC_27381173","title":"SLC6A4 promoter region methylation and socio-emotional stress response in very preterm and full-term infants.","date":"2016","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/27381173","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35948542","id":"PMC_35948542","title":"Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35948542","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26261165","id":"PMC_26261165","title":"Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.","date":"2015","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26261165","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17944904","id":"PMC_17944904","title":"Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials.","date":"2007","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17944904","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31708117","id":"PMC_31708117","title":"A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31708117","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32580314","id":"PMC_32580314","title":"Huntington's Disease-An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32580314","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36114180","id":"PMC_36114180","title":"Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters.","date":"2022","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36114180","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24385047","id":"PMC_24385047","title":"SLC6A4 polymorphism, population genetics, and psychiatric traits.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24385047","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24069428","id":"PMC_24069428","title":"A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24069428","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23583772","id":"PMC_23583772","title":"Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population.","date":"2013","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23583772","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35023827","id":"PMC_35023827","title":"A novel and accurate full-length HTT mouse model for Huntington's disease.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35023827","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29331882","id":"PMC_29331882","title":"Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism.","date":"2017","source":"Comprehensive psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29331882","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30447571","id":"PMC_30447571","title":"Epigenetic variation at the SLC6A4 gene promoter in mother-child pairs with major depressive disorder.","date":"2018","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30447571","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23635830","id":"PMC_23635830","title":"Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.","date":"2013","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23635830","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17299512","id":"PMC_17299512","title":"Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17299512","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24392134","id":"PMC_24392134","title":"Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24392134","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30643413","id":"PMC_30643413","title":"Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/30643413","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18614671","id":"PMC_18614671","title":"Emotion-induced retrograde amnesia is determined by a 5-HTT genetic polymorphism.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18614671","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34509065","id":"PMC_34509065","title":"Role of NR3C1 and SLC6A4 methylation in the HPA axis regulation in burnout.","date":"2021","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/34509065","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24229495","id":"PMC_24229495","title":"Gender-specific association of the SLC6A4 and DRD2 gene variants in bipolar disorder.","date":"2013","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24229495","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38433266","id":"PMC_38433266","title":"Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype.","date":"2024","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/38433266","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20002020","id":"PMC_20002020","title":"Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens.","date":"2010","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/20002020","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25710844","id":"PMC_25710844","title":"A meta-analysis of the associations between the SLC6A4 promoter polymorphism (5HTTLPR) and the risk for alcohol dependence.","date":"2015","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25710844","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30524254","id":"PMC_30524254","title":"Modulation of Fear and Arousal Behavior by Serotonin Transporter (5-HTT) Genotypes in Newly Hatched Chickens.","date":"2018","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30524254","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28387881","id":"PMC_28387881","title":"REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.","date":"2017","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/28387881","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31244679","id":"PMC_31244679","title":"Downregulation of Orco and 5-HTT Alters Nestmate Discrimination in the Subterranean Termite Odontotermes formosanus (Shiraki).","date":"2019","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31244679","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27124581","id":"PMC_27124581","title":"The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27124581","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31695145","id":"PMC_31695145","title":"Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31695145","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31814404","id":"PMC_31814404","title":"Nucleation Inhibition of Huntingtin Protein (htt) by Polyproline PPII Helices: A Potential Interaction with the N-Terminal α-Helical Region of Htt.","date":"2019","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31814404","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25751280","id":"PMC_25751280","title":"Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.","date":"2015","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/25751280","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36048753","id":"PMC_36048753","title":"HTT (huntingtin) and RAB7 co-migrate retrogradely on a signaling LAMP1-containing late endosome during axonal injury.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36048753","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24760870","id":"PMC_24760870","title":"Mice with compromised 5-HTT function lack phosphotyrosine-mediated inhibitory control over prefrontal 5-HT responses.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24760870","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33526821","id":"PMC_33526821","title":"Association of SLC6A4 methylation with long-term outcomes after stroke: focus on the interaction with suicidal ideation.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33526821","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29487159","id":"PMC_29487159","title":"Molecular and functional characterization of the Gulf toadfish serotonin transporter SLC6A4.","date":"2018","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29487159","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8632190","id":"PMC_8632190","title":"Allelic variation of human serotonin transporter gene expression.","date":"1996","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8632190","citation_count":1731,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12130784","id":"PMC_12130784","title":"Serotonin transporter genetic variation and the response of the human amygdala.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12130784","citation_count":1573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15880108","id":"PMC_15880108","title":"5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.","date":"2005","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15880108","citation_count":1391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391209","id":"PMC_10391209","title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391209","citation_count":1381,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19531786","id":"PMC_19531786","title":"Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.","date":"2009","source":"JAMA","url":"https://pubmed.ncbi.nlm.nih.gov/19531786","citation_count":1107,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21199959","id":"PMC_21199959","title":"The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.","date":"2011","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21199959","citation_count":942,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16642437","id":"PMC_16642437","title":"Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16642437","citation_count":918,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20231323","id":"PMC_20231323","title":"Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.","date":"2010","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20231323","citation_count":898,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18583979","id":"PMC_18583979","title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18583979","citation_count":817,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7681602","id":"PMC_7681602","title":"Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7681602","citation_count":737,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19506906","id":"PMC_19506906","title":"Candidate gene studies of ADHD: a meta-analytic review.","date":"2009","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19506906","citation_count":713,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15188158","id":"PMC_15188158","title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.","date":"2004","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15188158","citation_count":613,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15699291","id":"PMC_15699291","title":"A susceptibility gene for affective disorders and the response of the human amygdala.","date":"2005","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15699291","citation_count":570,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15867106","id":"PMC_15867106","title":"The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.","date":"2005","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15867106","citation_count":558,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27049939","id":"PMC_27049939","title":"X-ray structures and mechanism of the human serotonin transporter.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27049939","citation_count":530,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17949693","id":"PMC_17949693","title":"Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17949693","citation_count":527,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15592465","id":"PMC_15592465","title":"Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.","date":"2004","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15592465","citation_count":509,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7865169","id":"PMC_7865169","title":"Organization of the human serotonin transporter gene.","date":"1994","source":"Journal of neural transmission. General section","url":"https://pubmed.ncbi.nlm.nih.gov/7865169","citation_count":508,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15563601","id":"PMC_15563601","title":"Social supports and serotonin transporter gene moderate depression in maltreated children.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15563601","citation_count":503,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7684072","id":"PMC_7684072","title":"Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.","date":"1993","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7684072","citation_count":471,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15241435","id":"PMC_15241435","title":"Gene-environment interaction analysis of serotonin system markers with adolescent depression.","date":"2004","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15241435","citation_count":460,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16458264","id":"PMC_16458264","title":"Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16458264","citation_count":453,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15108187","id":"PMC_15108187","title":"Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15108187","citation_count":440,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16402131","id":"PMC_16402131","title":"Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16402131","citation_count":440,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8602004","id":"PMC_8602004","title":"Polymorphism in serotonin transporter gene associated with susceptibility to major depression.","date":"1996","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8602004","citation_count":437,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30845820","id":"PMC_30845820","title":"No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.","date":"2019","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30845820","citation_count":378,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50649,"output_tokens":2122,"usd":0.091888},"stage2":{"model":"claude-opus-4-6","input_tokens":5409,"output_tokens":2299,"usd":0.12678},"total_usd":0.517336,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":63792,"output_tokens":6128,"usd":0.141648},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8726,"output_tokens":2442,"usd":0.15702}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"The serotonin transporter SERT (SLC6A4) forms oligomeric structures; treatment with sulfhydryl oxidizing agents and the homobifunctional cross-linker dimethyl suberimidate (DMS) of recombinant rat SERT1 expressed in HEK293 cells generated adducts of 130–180 kDa and 220–270 kDa, indicating an oligomeric quaternary structure.\",\n      \"method\": \"Chemical cross-linking with DMS and sulfhydryl oxidizing agents followed by SDS-PAGE in transiently transfected HEK293 cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — direct biochemical cross-linking in recombinant system; single study, single method\",\n      \"pmids\": [\"8925924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The SLC6A4 intron 2 VNTR (STin2) functions as a transcriptional regulatory enhancer, and the transcription factors YB-1 and CTCF differentially regulate it: YB-1 binds the VNTR in a sequence-specific manner and drives allele-dependent reporter gene expression, while CTCF blocks YB-1 binding and suppresses YB-1-directed transcription, providing a molecular mechanism for allele-dependent differences in SLC6A4 expression.\",\n      \"method\": \"Yeast one-hybrid screen, in vitro DNA-binding assays, reporter gene assays with exogenous YB-1 and CTCF\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — yeast one-hybrid identification of binding partner confirmed by in vitro binding and functional reporter assays with multiple orthogonal methods\",\n      \"pmids\": [\"15229244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In mice with genetically deleted or developmentally reduced 5-HTT (SLC6A4) function, prefrontal 5-HT1A receptor-mediated inhibitory currents are amplified and show enhanced coupling to Kir3 channels; this dysregulation is normally controlled by Src family tyrosine kinase-dependent phosphotyrosine inhibition of the 5-HT1A receptor signaling pathway, which is lost when 5-HTT function is compromised.\",\n      \"method\": \"Electrophysiological recording in prefrontal cortex slices from 5-HTT knockout mice and SSRI-treated mice; pharmacological inhibition of Src kinases and tyrosine phosphatases\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined electrophysiological phenotype, confirmed by pharmacological dissection of tyrosine kinase pathway with multiple orthogonal approaches\",\n      \"pmids\": [\"24760870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The Gulf toadfish SLC6A4 ortholog encodes a functional serotonin transporter with a Km of 2.08 μmol/l for 5-HT uptake (similar to human SERT) when expressed in Xenopus laevis oocytes; systemic SSRI (fluoxetine) blockade in vivo dose-dependently elevated plasma 5-HT, demonstrating that SERT controls circulating 5-HT clearance.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes with transport kinetic assays; in vivo SSRI administration with plasma 5-HT measurement\",\n      \"journal\": \"The Journal of experimental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted transport in Xenopus oocytes with kinetic parameters; single study but ortholog characterization\",\n      \"pmids\": [\"29487159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"5-HTT (SLC6A4) knockout mice exhibit impaired fear extinction recall and delayed extinction learning, accompanied by increased theta synchronization between the lateral amygdala and infralimbic prefrontal cortex during extinction, demonstrating a direct role of SERT in regulating amygdala-prefrontal cortical circuit dynamics underlying fear extinction.\",\n      \"method\": \"Pavlovian fear conditioning with simultaneous electrophysiological recording in 5-HTT+/+, +/-, and -/- mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral and neurophysiological phenotype across three genotypes\",\n      \"pmids\": [\"21818344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Decreased peripheral 5-HTT (SLC6A4) function in 5-HTT-deficient mice leads to elevated intestinal serotonin and increased 5-HT3 receptor stimulation, resulting in increased intestinal permeability, establishing a mechanistic link between SERT loss of function and gut barrier dysfunction that could permit bacterial endotoxin leakage.\",\n      \"method\": \"Mechanistic analysis in 5-HTT-deficient mouse model with intestinal permeability measurements\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with defined cellular/physiological phenotype; single study\",\n      \"pmids\": [\"24815315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Genetic variation in ITGB3 is associated with expression levels of both ITGB3 and SLC6A4 in CEPH individuals, and ITGB3 and SLC6A4 expression levels are correlated across murine and human tissues, suggesting ITGB3 regulates SLC6A4 expression as a trans-acting quantitative trait locus affecting platelet serotonin levels.\",\n      \"method\": \"Expression QTL analysis using publicly available genomic resources (murine and human expression data), genotype-expression correlation in CEPH families\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — correlation and eQTL analysis without direct functional validation of the regulatory mechanism\",\n      \"pmids\": [\"16721604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The SLC6A4 promoter region is subject to DNA methylation that inversely correlates with SLC6A4 mRNA expression levels in human placenta (independently of genetic 5-HTTLPR/STin2 genotype), demonstrating that epigenetic methylation is a predominant regulator of SLC6A4 expression in this tissue.\",\n      \"method\": \"Bisulfite sequencing of SLC6A4 promoter CpGs combined with RT-qPCR mRNA quantification in placental tissue; genotyping of functional polymorphisms as covariates\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct correlation of site-specific methylation with mRNA in tissue, with genetic polymorphisms controlled; single study\",\n      \"pmids\": [\"28650965\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC6A4 encodes the serotonin transporter (SERT), a membrane-bound oligomeric protein that clears 5-HT from synaptic clefts with defined transport kinetics (Km ~2 μmol/l); its expression is transcriptionally regulated by the intron 2 VNTR through YB-1 (activator) and CTCF (repressor) binding, and epigenetically by promoter CpG methylation; loss of SERT function dysregulates prefrontal 5-HT1A receptor signaling via a Src tyrosine kinase–dependent mechanism, impairs amygdala-prefrontal theta synchrony underlying fear extinction, and elevates peripheral intestinal serotonin leading to increased gut permeability.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI need to carefully classify each paper before extracting discoveries.\n\n**Classification:**\n\nMany papers in this corpus are about HTT (huntingtin gene, Huntington's disease), which is a completely different gene from SLC6A4 (serotonin transporter). These must be EXCLUDED as alias collisions (HTT ≠ SLC6A4, and \"5-HTT\" when referring to the serotonin transporter IS SLC6A4, but papers specifically about the huntingtin protein HTT are not).\n\nPapers [2], [5], [7], [8], [11], [15], [17], [19], [21], [23], [26], [27], [36], [38], [39], [40], [42], [45], [52], [53], [56], [59], [63], [64], [68], [72], [77], [87], [91], [94], [95], [97] — all about huntingtin HTT → EXCLUDE\n\nPaper [92] is about termite 5-HTT — symbol collision with non-orthologous organism context (termite) → EXCLUDE\n\nPapers that are purely epidemiological/association/GWAS/expression/methylation studies with no mechanistic findings → skip silently (no Discovery entry created).\n\n**KEPT papers with mechanistic content:**\n\n- PMID 8925924 [35]: SERT1 oligomeric structure\n- PMID 8632190 [additional #1]: Allelic variation of 5-HTT promoter activity\n- PMID 7681602 [additional #11]: Molecular cloning, Na+/Cl- dependent transport, antidepressant sensitivity\n- PMID 7684072 [additional #22]: Primary structure, 12 TM segments, phosphorylation sites, single gene\n- PMID 27049939 [additional #17]: X-ray crystal structure of human SERT, mechanism\n- PMID 15229244 [31]: YB-1 and CTCF regulate 5-HTT VNTR intron 2 enhancer\n- PMID 16642437 [additional #8]: Triallelic HTTLPR, AP2 binding site, expression assays\n- PMID 16402131 [additional #26]: Simultaneous genotyping of functional loci\n- PMID 15188158 [additional #14]: Reduced SERT mRNA and protein in UC and IBS (molecular defect)\n- PMID 21818344 [16]: 5-HTT deficient mice — fear extinction, amygdala-PFC theta synchrony\n- PMID 24760870 [98]: Tyrosine kinase-dependent regulation of 5-HT1A receptor signaling in 5-HTT compromised mice\n- PMID 12130784 [additional #2]: 5-HTTLPR short allele → reduced expression → amygdala hyperreactivity (fMRI)\n- PMID 15880108 [additional #4]: 5-HTTLPR morphometric + functional neuroimaging, amygdala-cingulate circuit\n- PMID 15592465 [additional #19]: Amygdala-prefrontal coupling depends on SLC6A4 genotype\n- PMID 18824000 [6]: Review of gene-based discoveries for SLC6A4/SERT function\n- PMID 17203304 [14]: Epistasis between SLC6A4 and ITGB3 for serotonin levels\n- PMID 16721604 [55]: ITGB3 expression correlated with SLC6A4 expression\n- PMID 23630162 [51]: Gain-of-function SERT variants (I425V, LA allele) in Tourette's disorder\n- PMID 29487159 [100]: Toadfish SERT — Km, transport kinetics, SSRI inhibition (ortholog functional characterization)\n- PMID 21857948 [24]: 5-Htt genotype × prenatal stress → MAPK, neurotrophin, Wnt signaling\n- PMID 25335169 [50]: Prenatal stress + 5-Htt deficiency → genome-wide methylation changes, MBP methylation\n- PMID 28821725 [60]: Maternal Slc6a4 mutation + prenatal stress → attenuated transcriptomic/epigenetic response in embryonic brains\n- PMID 18347599 [4]: Epistasis between SLC6A4 and BDNF on amygdala-rAC circuit volume\n\nMost of the remaining papers are pure association, epidemiology, or methylation biomarker studies with no mechanistic findings — I will not create Discovery entries for those.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"The human serotonin transporter (SERT/SLC6A4) was molecularly cloned from placenta, revealing a 630-amino acid protein with 12 predicted transmembrane segments, Na⁺- and Cl⁻-dependent high-affinity serotonin transport (Km ~463 nM), and sensitivity to antidepressants (paroxetine, fluoxetine, imipramine) and cocaine/amphetamine. The gene was mapped to chromosome 17q11.1–17q12 and shown to encode both brain and platelet 5-HT transporters.\",\n      \"method\": \"cDNA cloning, transfection into HeLa cells, radiotracer uptake assay, pharmacological inhibition, somatic cell hybrid mapping, in situ hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original functional reconstitution in heterologous cells with transport kinetics, pharmacology, and chromosomal mapping; independently confirmed by concurrent platelet SERT cloning\",\n      \"pmids\": [\"7681602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The primary structure of human platelet SERT (SLC6A4) is identical to the brain serotonin transporter, encoded by a single gene on chromosome 17. The 630-aa protein contains two putative N-glycosylation sites in the second extracellular loop, consensus phosphorylation sites for cAMP-dependent protein kinase in the N-terminal cytoplasmic region, and three potential PKC phosphorylation sites.\",\n      \"method\": \"PCR-based cDNA cloning and sequencing, hydropathicity analysis, chromosomal assignment\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequence determination with structural prediction; replicated by simultaneous independent cloning (PMID 7681602)\",\n      \"pmids\": [\"7684072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human SLC6A4 gene spans approximately 31 kb and is composed of 14 exons. A variable number tandem repeat (VNTR) polymorphism was identified within the gene, providing the first structural framework for genetic studies of serotonin transporter regulation.\",\n      \"method\": \"Genomic library screening, exon mapping, DNA sequencing\",\n      \"journal\": \"Journal of neural transmission. General section\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genomic characterization; foundational structural finding repeatedly referenced\",\n      \"pmids\": [\"7865169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"A polymorphic repetitive element in the 5'-flanking transcriptional regulatory region of SLC6A4 (5-HTTLPR) drives allele-dependent differential promoter activity: the long (L) allele confers approximately 2–3-fold higher basal transcription and 5-HT transporter expression than the short (S) allele in transfected cells and lymphoblasts, establishing this as a functional regulatory variant.\",\n      \"method\": \"Reporter gene (luciferase) transfection assays in serotonergic and non-serotonergic cells, lymphoblast 5-HTT expression analysis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional promoter assays with allele-specific constructs; one of the most-cited mechanistic findings for this gene\",\n      \"pmids\": [\"8632190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The recombinant rat serotonin transporter SERT1 expressed in HEK293 cells forms oligomeric complexes: treatment with sulfhydryl-oxidizing agents and the homobifunctional cross-linker DMS generated adducts of 130–180 kDa and 220–270 kDa, indicating that the membrane-bound transporter has a quaternary oligomeric structure.\",\n      \"method\": \"Transient transfection in HEK293 cells, chemical cross-linking (dimethyl suberimidate), SDS-PAGE/immunoblot\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chemical cross-linking in heterologous cells; single study, rat ortholog\",\n      \"pmids\": [\"8925924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The STin2 VNTR in intron 2 of SLC6A4 is a polymorphic transcriptional regulatory element; the nine-copy repeat allele (STin2.9) is significantly associated with unipolar depressive disorder, providing the first evidence that intronic variation in SLC6A4 may affect gene expression and disease risk.\",\n      \"method\": \"PCR genotyping, case-control association study, allele frequency comparison\",\n      \"journal\": \"Lancet\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — association study; mechanistic link to expression is inferred, not directly demonstrated in this paper\",\n      \"pmids\": [\"8602004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The SLC6A4 intron 2 VNTR is a transcriptional regulatory domain whose allelic variants drive differential reporter gene expression in vivo and in vitro. Yeast one-hybrid screening identified the transcription factor YB-1 as a sequence-specific VNTR-binding activator; CTCF (CCTC-binding factor) blocks YB-1 binding to VNTR sequences and antagonizes YB-1-directed reporter expression, providing a molecular mechanism for allele-dependent differential transcription.\",\n      \"method\": \"Yeast one-hybrid screening, reporter gene assays, electrophoretic mobility shift assay (EMSA), in vitro binding assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast one-hybrid plus in vitro EMSA plus reporter assays converging on same conclusion; multiple orthogonal methods in one study\",\n      \"pmids\": [\"15229244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mucosal serotonin transporter (SERT) mRNA and protein are significantly reduced in patients with ulcerative colitis, IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C), without a corresponding decrease in enterochromaffin cell numbers or basal/stimulated 5-HT release, implicating defective 5-HT reuptake via SLC6A4 as an intrinsic gastrointestinal molecular defect in these disorders.\",\n      \"method\": \"Rectal biopsy analysis, quantitative RT-PCR for SERT mRNA, immunohistochemistry for SERT protein, 5-HT release assays\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular methods (mRNA, protein, functional release assay) in human tissue; replicated across multiple disease groups\",\n      \"pmids\": [\"15188158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The 5-HTTLPR short allele of SLC6A4 is associated with reduced gray matter volume in perigenual anterior cingulate cortex and amygdala, and with relative uncoupling of the amygdala–cingulate feedback circuit during processing of fearful stimuli. The magnitude of amygdala-cingulate coupling inversely predicted ~30% of variation in temperamental anxiety, establishing a developmental, systems-level neural mechanism for the genetic susceptibility conferred by the short allele.\",\n      \"method\": \"Multimodal neuroimaging (structural MRI volumetry + fMRI functional connectivity), large healthy-subject cohort (N≈114)\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal neuroimaging modalities in a large sample; replicated amygdala finding from prior work and extended to structural and circuit level\",\n      \"pmids\": [\"15880108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Carriers of the SLC6A4 short allele show stronger amygdala activation and greater functional coupling between amygdala and ventromedial prefrontal cortex during presentation of aversive stimuli compared with long-allele homozygotes, directly linking SERT genotype to amygdala-prefrontal serotonergic circuitry.\",\n      \"method\": \"fMRI (BOLD), genotyping of 5-HTTLPR, passive viewing of aversive vs. neutral pictures\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — independent replication of amygdala hyperreactivity finding with added prefrontal connectivity; multiple independent labs\",\n      \"pmids\": [\"15592465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The 5-HTTLPR is functionally triallelic: a common G→A substitution (rs25531) within the L allele creates an AP2 transcription-factor binding site, converting the L allele into a low-expressing L(G) allele functionally equivalent to the S allele. Expression assays in 62 lymphoblastoid cell lines demonstrated codominant allele action, with the L(A)/L(A) genotype conferring highest expression (~2-fold over S or L(G)). The gain-of-function L(A)/L(A) genotype was ~2-fold more common in OCD patients, establishing SERT overexpression as a risk mechanism for OCD.\",\n      \"method\": \"Luciferase reporter assays in raphe-derived cells, allele-specific expression in 62 lymphoblastoid lines, case-control genotyping (OCD probands + trios), transmission disequilibrium test\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reporter assays plus lymphoblastoid expression across 62 cell lines plus TDT replication; multiple orthogonal methods identifying a functional triallelic mechanism\",\n      \"pmids\": [\"16642437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ITGB3 (integrin beta-3) and SLC6A4 expression levels are correlated (r = 0.38–0.78) in murine and human datasets, and genetic variation in ITGB3 is associated with expression of both ITGB3 (P=0.012) and SLC6A4 (P=0.008), suggesting that ITGB3 acts as a trans-regulator of SLC6A4 expression and that epistatic interaction between the two genes influences serotonin levels.\",\n      \"method\": \"Public expression database analysis (murine and human), eQTL analysis in CEPH individuals, genetic association\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3-4 — expression correlation and eQTL from existing databases; no direct functional experiment demonstrating mechanism\",\n      \"pmids\": [\"16721604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SLC6A4 (5-HTTLPR S allele) and BDNF (Val66Met) exhibit biological epistasis at the neural systems level: the BDNF Met allele (which reduces BDNF secretion and 5-HT responsivity) protects against S-allele-driven volume reduction of the subgenual anterior cingulate cortex and against reduced structural connectivity between amygdala and anterior cingulate, demonstrating a gene–gene interaction between serotonergic and neurotrophic signaling pathways in emotion circuitry.\",\n      \"method\": \"Structural MRI volumetry and diffusion tensor imaging (structural connectivity) in healthy subjects (N=111), two-way ANOVA for genotype interaction\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two neuroimaging modalities in a reasonably sized sample; single lab but orthogonal structural measures converge\",\n      \"pmids\": [\"18347599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"5-HTT-deficient (SLC6A4 knockout) mice show impaired recall of conditioned fear extinction and delayed extinction learning, accompanied by increased theta synchronization between the lateral amygdala and infralimbic medial prefrontal cortex during extinction, establishing a causal role for SERT in amygdala-prefrontal circuit oscillatory dynamics underlying fear regulation.\",\n      \"method\": \"5-HTT knockout mouse model, Pavlovian fear conditioning, simultaneous local field potential recordings in lateral amygdala and mPFC, resident-intruder social defeat paradigm\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with simultaneous electrophysiological recordings and behavioral readout; direct mechanistic link between SERT loss and circuit-level oscillatory phenotype\",\n      \"pmids\": [\"21818344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gain-of-function SERT alleles (high-expressing 5-HTTLPR L(A) allele and the rare coding variant I425V) are enriched in Tourette's disorder probands, with I425V found at 1.57% in OCD/TD spectrum vs. 0.15% in controls, indicating that SERT overactivity (not just underactivity) contributes to serotonergic abnormalities in TD.\",\n      \"method\": \"Case-control genotyping (N=151 TD probands, N=858 controls), triallelic 5-HTTLPR/rs25531/rs25532 haplotyping, rare variant (I425V) sequencing\",\n      \"journal\": \"Movement disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic association with functional alleles; mechanism inferred from known functional consequences of these variants\",\n      \"pmids\": [\"23630162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mice with compromised 5-HTT function (genetic deletion or neonatal SSRI treatment) exhibit amplified 5-HT1A receptor-mediated inhibitory currents in prefrontal pyramidal neurons, with enhanced downstream coupling to Kir3 channels. This hyperresponsiveness is due to loss of tyrosine kinase-dependent inhibitory control: in wild-type mice, Src family tyrosine kinase inhibition mimics the amplified 5-HT1A response, while tyrosine phosphatase inhibition reduces it in 5-HTT-deficient mice.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology in prefrontal cortex slices, 5-HTT knockout mice, neonatal fluoxetine treatment, pharmacological manipulation of tyrosine kinases and phosphatases\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro electrophysiology with genetic KO plus pharmacological rescue; identifies a specific tyrosine kinase signaling mechanism linking SERT to 5-HT1A receptor regulation\",\n      \"pmids\": [\"24760870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"X-ray crystallographic structures of human SERT (SLC6A4) at 3.15 Å resolution bound to antidepressants (S)-citalopram or paroxetine reveal that these drugs lock SERT in an outward-open conformation by occupying the central binding site between TM helices 1, 3, 6, 8, and 10, directly blocking serotonin access. An allosteric site was identified at the periphery of the extracellular vestibule between EL4/EL6 and TM1/6/10/11; occupancy of this site sterically hinders ligand unbinding from the central site, explaining (S)-citalopram's allosteric action.\",\n      \"method\": \"X-ray crystallography of thermostabilized human SERT at 3.15 Å, co-crystallization with (S)-citalopram and paroxetine, structure–function analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution crystal structures of the human transporter with bound drugs; defines transport mechanism and two drug-binding sites\",\n      \"pmids\": [\"27049939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The Gulf toadfish SERT (SLC6A4 ortholog) encodes a 673-aa protein with 83% similarity to zebrafish SERT. When expressed in Xenopus oocytes, it demonstrates Na⁺/Cl⁻-dependent serotonin transport with a Km of 2.08 μmol/l, similar to zebrafish and human SERT. Systemic SSRI (fluoxetine) administration dose-dependently increases plasma 5-HT, indicating that peripheral SERT normally maintains low circulating 5-HT in teleosts lacking platelets.\",\n      \"method\": \"cRNA expression in Xenopus oocytes, radiotracer uptake kinetics, in vivo fluoxetine administration with plasma 5-HT measurement\",\n      \"journal\": \"The Journal of experimental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution in Xenopus oocytes with transport kinetics, combined with in vivo pharmacological validation; teleost ortholog\",\n      \"pmids\": [\"29487159\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC6A4 encodes the serotonin transporter (SERT), a Na⁺/Cl⁻-dependent 12-transmembrane-segment protein that mediates high-affinity reuptake of serotonin from the synapse; X-ray structures at 3.15 Å show antidepressants (SSRIs) lock SERT in an outward-open conformation by occupying the central substrate-binding site, while an allosteric site in the extracellular vestibule modulates drug unbinding; the 5-HTTLPR promoter polymorphism and triallelic rs25531 variant drive allele-dependent differential transcription (regulated by YB-1/CTCF at the intron 2 VNTR), with the low-expressing short allele linked to amygdala hyperreactivity, uncoupling of the amygdala–cingulate fear-extinction circuit, and altered prefrontal 5-HT1A receptor signaling via tyrosine kinase-dependent mechanisms; SERT also forms oligomers at the membrane and is functionally deficient in gastrointestinal disorders including IBS and ulcerative colitis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC6A4 encodes the serotonin transporter (SERT), a plasma membrane Na⁺/Cl⁻-dependent transporter that clears serotonin (5-HT) from extracellular space with a Km of ~2 µmol/l, functioning as an oligomeric complex and serving as the primary target of selective serotonin reuptake inhibitors (SSRIs) [PMID:29487159, PMID:8925924]. Transcription of SLC6A4 is regulated by the intron 2 VNTR enhancer, where YB-1 drives allele-dependent expression and CTCF acts as a repressor by blocking YB-1 binding, and is further modulated by promoter CpG methylation that inversely correlates with mRNA levels independently of cis-polymorphism genotype [PMID:15229244, PMID:28650965]. Loss of SERT function in knockout mice amplifies prefrontal 5-HT1A receptor signaling through loss of Src family kinase–dependent inhibitory phosphorylation, disrupts amygdala–prefrontal theta synchrony required for fear extinction, and elevates intestinal serotonin leading to 5-HT3 receptor–mediated increases in gut permeability [PMID:24760870, PMID:21818344, PMID:24815315].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Whether SERT functions as a monomer or higher-order complex was unknown; chemical cross-linking revealed oligomeric adducts, establishing that SERT assembles into multimeric structures.\",\n      \"evidence\": \"DMS cross-linking and sulfhydryl oxidation of recombinant rat SERT in HEK293 cells with SDS-PAGE analysis\",\n      \"pmids\": [\"8925924\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry of the oligomer not determined\", \"Functional relevance of oligomerization (e.g. transport activity dependence) not tested\", \"Not confirmed with native tissue or additional cross-linkers\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The mechanism by which the SLC6A4 intron 2 VNTR drove allele-dependent expression was unknown; identification of YB-1 as a sequence-specific activator and CTCF as a competitive repressor provided the first transcription factor–level explanation for VNTR-dependent transcriptional regulation.\",\n      \"evidence\": \"Yeast one-hybrid screen, in vitro DNA-binding assays, and reporter gene assays with exogenous YB-1 and CTCF\",\n      \"pmids\": [\"15229244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin-level regulation at the endogenous locus not demonstrated\", \"Relative contributions of YB-1/CTCF versus other factors in vivo not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether trans-acting loci regulate SLC6A4 expression was unexplored; eQTL analysis identified ITGB3 genetic variation as correlated with SLC6A4 expression levels, suggesting a trans-regulatory relationship.\",\n      \"evidence\": \"Expression QTL analysis in murine and human tissues with genotype-expression correlation in CEPH families\",\n      \"pmids\": [\"16721604\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Correlation-based without direct functional validation of ITGB3→SLC6A4 regulatory mechanism\", \"No perturbation or rescue experiment performed\", \"Causal direction of regulation not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Whether SERT loss affects circuit-level neural dynamics underlying behavior was unresolved; 5-HTT knockout mice showed impaired fear extinction with altered amygdala–prefrontal theta synchrony, establishing SERT as a regulator of inter-regional circuit dynamics for emotional learning.\",\n      \"evidence\": \"Pavlovian fear conditioning with simultaneous in vivo electrophysiology in 5-HTT+/+, +/−, and −/− mice\",\n      \"pmids\": [\"21818344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether circuit phenotype is developmental or acute was not dissected\", \"Contribution of specific serotonin receptor subtypes to the theta synchrony change not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether epigenetic marks regulate SLC6A4 independently of cis-genetic polymorphisms was unclear; promoter CpG methylation inversely correlated with SLC6A4 mRNA in human placenta after controlling for 5-HTTLPR/STin2 genotype, establishing methylation as a genotype-independent expression regulator.\",\n      \"evidence\": \"Bisulfite sequencing of SLC6A4 promoter CpGs combined with RT-qPCR in human placental tissue, with genetic polymorphism covariates\",\n      \"pmids\": [\"28650965\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative — no experimental manipulation of methylation to demonstrate causality\", \"Tissue-specificity of this epigenetic regulation beyond placenta not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The intracellular signaling mechanism linking SERT loss to altered serotonin receptor function was unknown; electrophysiology in 5-HTT KO prefrontal cortex revealed that Src kinase–dependent phosphotyrosine inhibition of 5-HT1A–Kir3 channel coupling is lost when SERT is absent, identifying the specific kinase pathway mediating receptor dysregulation.\",\n      \"evidence\": \"Whole-cell recording in prefrontal cortex slices from 5-HTT KO and SSRI-treated mice with pharmacological Src kinase and phosphatase inhibition\",\n      \"pmids\": [\"24760870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation of 5-HT1A receptor by Src not demonstrated biochemically\", \"Whether this mechanism operates in human prefrontal cortex is untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Whether peripheral SERT loss affects gut barrier function was unexplored; 5-HTT-deficient mice showed elevated intestinal serotonin driving 5-HT3 receptor–dependent increases in gut permeability, linking SERT to intestinal barrier integrity.\",\n      \"evidence\": \"Intestinal permeability measurements in 5-HTT-deficient mouse model\",\n      \"pmids\": [\"24815315\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study; replication in independent models needed\", \"Whether gut permeability change is reversible with 5-HT3 antagonism not fully established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Quantitative transport parameters for a vertebrate SLC6A4 ortholog had not been determined in a reconstituted system; heterologous expression yielded a Km of ~2 µmol/l for 5-HT, and in vivo SSRI blockade elevated plasma 5-HT, confirming SERT as the principal clearance mechanism for circulating serotonin.\",\n      \"evidence\": \"Heterologous expression in Xenopus oocytes with radiolabeled 5-HT transport kinetics; in vivo fluoxetine administration in Gulf toadfish\",\n      \"pmids\": [\"29487159\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinetic parameters from non-mammalian ortholog; human SERT kinetics in same system not directly compared\", \"Ion stoichiometry of transport not characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of SERT oligomerization and its functional significance for transport activity remain unresolved, as does the in vivo chromatin architecture governing the interplay between VNTR-bound transcription factors, promoter methylation, and trans-regulatory inputs in determining tissue-specific SLC6A4 expression.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the oligomeric SERT complex\", \"No integrated in vivo model combining VNTR enhancer regulation, epigenetic methylation, and trans-QTL effects\", \"Causal manipulation of promoter methylation on SLC6A4 expression not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"YB-1\", \"CTCF\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SLC6A4 encodes the sodium- and chloride-dependent serotonin transporter (SERT), a 630-amino-acid, 12-transmembrane-segment protein that mediates high-affinity reuptake of 5-HT from the extracellular space in both the central nervous system and peripheral tissues, thereby terminating serotonergic signaling [PMID:7681602, PMID:7684072]. X-ray crystallography of human SERT at 3.15 Å resolution shows that SSRI antidepressants lock the transporter in an outward-open conformation by occupying a central substrate-binding site between TM1/3/6/8/10, while an allosteric vestibular site sterically impedes drug unbinding [PMID:27049939]. Transcription from SLC6A4 is regulated by the functionally triallelic 5-HTTLPR/rs25531 promoter polymorphism, where the L(A) allele drives ~2-fold higher expression than the S or L(G) alleles, and by an intron 2 VNTR whose activity is modulated by YB-1 binding opposed by CTCF [PMID:16642437, PMID:15229244]. Loss of SERT function—whether by the low-expressing S allele, genetic knockout, or pharmacological inhibition—results in amygdala hyperreactivity, uncoupling of amygdala–anterior cingulate fear-extinction circuitry, and amplified prefrontal 5-HT1A receptor signaling via loss of Src-family tyrosine kinase–dependent inhibitory control [PMID:15880108, PMID:21818344, PMID:24760870].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Molecular cloning of human SERT from placenta and platelets established that a single gene on chromosome 17q encodes a 630-aa, 12-TM protein responsible for Na⁺/Cl⁻-dependent, antidepressant-sensitive 5-HT reuptake in both brain and periphery, resolving the molecular identity of the serotonin transporter.\",\n      \"evidence\": \"cDNA cloning, HeLa cell reconstitution with radiotracer uptake and pharmacological inhibition, somatic cell hybrid mapping\",\n      \"pmids\": [\"7681602\", \"7684072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-translational modifications predicted from sequence but not functionally validated\", \"Oligomeric state in native membranes unknown\", \"Three-dimensional structure unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of the 5-HTTLPR promoter polymorphism demonstrated that common genetic variation directly modulates SLC6A4 transcription, with the long allele conferring ~2–3-fold higher expression than the short allele, providing the first functional regulatory variant for the serotonin system.\",\n      \"evidence\": \"Luciferase reporter assays in serotonergic and non-serotonergic cells, lymphoblast expression analysis\",\n      \"pmids\": [\"8632190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin context and in vivo transcription rates not assessed\", \"Effect of the intron 2 VNTR on expression not yet mechanistically dissected\", \"Whether S-allele effect is cell-type-specific was untested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Converging neuroimaging and molecular studies showed that the low-expressing S allele reduces cingulate/amygdala gray matter volume and uncouples the amygdala–anterior cingulate feedback circuit during fear processing, while molecular work identified YB-1 and CTCF as antagonistic transcription factors mediating allele-dependent expression at the intron 2 VNTR, establishing both neural systems-level and molecular mechanisms for genetic risk.\",\n      \"evidence\": \"Structural MRI and fMRI functional connectivity in large cohorts; yeast one-hybrid, EMSA, and reporter assays for VNTR regulators; mucosal biopsy qRT-PCR and immunohistochemistry in GI disease\",\n      \"pmids\": [\"15880108\", \"15592465\", \"15229244\", \"15188158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal direction from genotype to circuit phenotype not established (observational imaging)\", \"YB-1/CTCF mechanism demonstrated with reporters but not at endogenous locus\", \"Mechanism of mucosal SERT downregulation in IBS/UC not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that rs25531 renders 5-HTTLPR functionally triallelic—with L(G) equivalent to S—refined the genetic architecture of SLC6A4 expression and linked the high-expressing L(A)/L(A) genotype to OCD risk, demonstrating that SERT overexpression, not only underexpression, can be pathogenic.\",\n      \"evidence\": \"Luciferase reporter assays in raphe-derived cells, allele-specific expression across 62 lymphoblastoid lines, transmission disequilibrium test in OCD trios\",\n      \"pmids\": [\"16642437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct measurement of synaptic 5-HT clearance by genotype in human brain\", \"OCD association not yet replicated in large independent cohorts at time of publication\", \"How overexpression leads to OCD-spectrum phenotypes mechanistically was unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Serotonin transporter knockout mice exhibited impaired fear extinction recall with increased amygdala–prefrontal theta synchrony, causally linking SERT loss to oscillatory dysfunction in the fear-extinction circuit and going beyond the correlational human imaging data.\",\n      \"evidence\": \"5-HTT knockout mice with simultaneous local field potential recordings in lateral amygdala and mPFC during fear conditioning\",\n      \"pmids\": [\"21818344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether circuit phenotype is developmental or acute consequence of SERT loss is unresolved\", \"Rescue by SERT re-expression not performed\", \"Translational relevance to human S-allele carriers is indirect\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Electrophysiology in prefrontal cortex slices from 5-HTT-deficient mice identified a specific intracellular mechanism: loss of SERT amplifies 5-HT1A receptor–Kir3 channel coupling through reduced Src-family tyrosine kinase–dependent inhibitory control, explaining how transporter loss reshapes postsynaptic serotonergic signaling.\",\n      \"evidence\": \"Whole-cell patch-clamp in PFC slices from KO and neonatal fluoxetine-treated mice, pharmacological manipulation of tyrosine kinases and phosphatases\",\n      \"pmids\": [\"24760870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific Src-family kinase isoform responsible not identified\", \"Whether this mechanism operates in human cortex is untested\", \"Relationship between amplified 5-HT1A signaling and behavioral phenotypes not directly demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The first X-ray crystal structures of human SERT resolved the atomic basis of antidepressant action: SSRIs occupy a central substrate-binding site between TM helices to lock an outward-open state, while an allosteric vestibular site explains the slow off-rate of (S)-citalopram, providing a structural framework for drug design.\",\n      \"evidence\": \"3.15 Å X-ray crystallography of thermostabilized human SERT co-crystallized with (S)-citalopram and paroxetine\",\n      \"pmids\": [\"27049939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures captured only outward-open state; inward-open and occluded conformations unresolved\", \"Substrate (5-HT)-bound structure not obtained\", \"Thermostabilizing mutations may alter conformational dynamics\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the complete transport cycle structural dynamics (inward-open, occluded states with substrate), the cell-type-specific mechanisms governing mucosal SERT downregulation in gastrointestinal disease, whether SERT oligomerization is functionally required for transport in vivo, and the causal chain from 5-HTTLPR genotype through circuit-level phenotypes to psychiatric disease risk in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No substrate-bound or inward-facing structural state resolved\", \"SERT oligomeric stoichiometry and functional relevance in native membranes uncharacterized\", \"Causal genotype-to-disease pathway remains incompletely bridged in humans\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 16, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 4, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 9, 13, 15]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 16, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"YBX1\",\n      \"CTCF\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}